MLTX Lawsuit: Hagens Berman Scrutinizing MoonLake’s SLK Efficacy Claims After 90% Plunge; Focus on Nanobody vs. BIMZELX Superiority
Lead Partner Reed Kathrein Investigating Alleged Undisclosed Truth: Did SLK’s Nanobody Structure Truly Confer a Superior Clinical Benefit Over Monoclonal…
